Switch View
© BusinessWire
15.09.2025
ISIN: US14070B3096
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) and reminds investors of the September 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.09.2025
ISIN: US71711N1000
Pharma-Bio Serv, Inc.
PBSV
LISTED
OTC
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025
News Preview
DORADO, PUERTO RICO / ACCESS Newswire / September 15, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied pr...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US5019761049
Kyverna Therapeutics, Inc.
KYTX
LISTED
NASDAQ
Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
News Preview
Oral presentation to include topline efficacy and safety data for 6 patients with up to 9 months of follow up...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ACCESSWIRE
15.09.2025
ISIN: US15870P3073
Champions Oncology Inc
CSBR
LISTED
NASDAQ
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
News Preview
This release contains a headline correction from the previous publication.Positive start to FY 2026 with steady revenue, data growth and new leadership HACKENSACK, NJ / ACCESS Newswire / September 15, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading translational oncology research organization, today announced its financial results for its...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
15.09.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign
News Preview
Bayer today announced a milestone in its Take Care, Now campaign with country superstar and five-time Entertainer of the Year, Luke Bryan, and Feeding America®, the nation’s largest hunger-relief organization. The effort builds on last year’s success to address both food insecurity and “hidden hunger” – nutrient gaps that can impact long-term heal...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.09.2025
ISIN: US15870P3073
Champions Oncology Inc
CSBR
LISTED
NASDAQ
Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
News Preview
Positive start to FY 2026 with steady revenue, data growth and new leadership HACKENSACK, NJ / ACCESS Newswire / September 15, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading translational oncology research organization, today announced its financial results for its first quarter of fiscal 2026, ended July 31, 2025.First Quarter and Recent...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: FR0000032526
Guerbet SA
GBT
LISTED
EURONEXT
Guerbet : Adjustment of 2025 full-year financial targets
News Preview
Adjustment of 2025 full-year financial targets...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04NET ASSET VALUEThe estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 12 September 2025 was 355.93p (cum income). ...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie's VRAYLAR® (cariprazine) Now Publicly Reimbursed in Alberta
News Preview
VRAYLAR® is an atypical antipsychotic medication with partial agonist activity at central dopamine D3 receptors in addition to targeted activity at D2 and serotonin 5-HT1A and 5-HT2A receptors.1MONTREAL, Sept. 15, 2025 /CNW/ - AbbVie (NYSE: ABBV) announced today that Alberta has listed VRAYLAR® (cariprazine) on its Health Drug Formulary.2
This li...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: IE00BTN1Y115
Medtronic PLC
MDT
LISTED
NYSE
Medtronic initiates global pivotal study of cardiac pacing in a new patient population
News Preview
Study to evaluate whether a new approach to pacing the heart can improve the lives of patients with heart failure with preserved ejection fraction (HFpEF) who have limited treatment options today
GALWAY, Ireland, Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the initiation of a...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US34962G1094
Forte Biosciences, Inc.
FBRX
LISTED
NASDAQ
Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
News Preview
Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, announced additional details from the oral presentation “FB102 prevents histological damage and mitigates gluten challenge-induced symptoms in a celiac disease phase 1b study - Jason Tye-Din...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Nutex Health Inc.(NUTX) Shareholders
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who purchased shares of NUTX during the class period listed are encouraged to...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
15.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Neogen Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before September 16, 2025 to Discuss Your Rights - NEOG
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Neogen Corporation (NASDAQ: NEOG).
Shareholders who purchased shares of NEOG during the class period listed are encouraged t...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Replimune Group, Inc. Class Action: The Gross Law Firm Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL).
Shareholders who purchased shares of REPL during the class period listed are encourage...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Contact The Gross Law Firm by September 19, 2025 Deadline to Join Class Action Against Alto Neuroscience, Inc.(ANRO)
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO).
Shareholders who purchased shares of ANRO during the class period listed are encourage...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights - CAPR
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR).
Shareholders who purchased shares of CAPR during the class period listed are enc...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
October 14, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against UNCY
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY).
Shareholders who purchased shares of UNCY during the class period listed are en...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Class Action Filed Against Semler Scientific, Inc. (SMLR) Seeking Recovery for Investors - Contact The Gross Law Firm
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders who purchased shares of SMLR during the class period listed are encoura...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
Shareholders that lost money on RxSight, Inc.(RXST) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST).
Shareholders who purchased shares of RXST during the class period listed are encouraged to con...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before November 7, 2025 to Discuss Your Rights - SVRA
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased shares of SVRA during the class period listed are encouraged to conta...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
Altimmune, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 6, 2025 to Discuss Your Rights - ALT
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. (NASDAQ: ALT).
Shareholders who purchased shares of ALT during the class period listed are encouraged to con...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Investors in LifeMD, Inc. Should Contact The Gross Law Firm Before October 25, 2025 to Discuss Your Rights - LFMD
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchased shares of LFMD during the class period listed are encouraged to cont...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
The Gross Law Firm Reminds Lantheus Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 10, 2025 - LNTH
News Preview
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders who purchased shares of LNTH during the class period listed are encoura...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US03969T1097
Arcturus Therapeutics Holdings Inc
ARCT
LISTED
NASDAQ
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
News Preview
NetworkNewsWire Editorial Coverage
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Innovation in RNA-based, immunotherapy and targeted therapeutics is not just aspirational, it's urgently needed. Aggressive cancers such as glioblastoma and pancreatic cancer remain devastatingly lethal, while pediatric rare diseases continue to claim too many young lives...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US5049221055
Labcorp Holdings Inc
LH
LISTED
NYSE
Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
News Preview
BURLINGTON, N.C. and MIAMI, Sept. 15, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today the completion of Labcorp's acquisition of select assets of BioReference Health, a wholl...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US68236V3024
ETHZilla Corporation
ETHZ
LISTED
NASDAQ
ETHZilla Announces Initial ETH Yield Allocation & Additional Stock Repurchases
News Preview
Company repurchased a total of approximately 6.0 million shares this month at an average price of $2.50 per share
Executing on deployment of ETH into L2 protocols
PALM BEACH, Fla., Sept. 15, 2025 /PRNewswire/ -- ETHZilla Corporation (Nasdaq: ETHZ), (the "Company" or "ETHZilla"), today announced it now has total holdings of 102,255 Ether ("ETH")...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US53630L2097
Lipella Pharmaceuticals. Inc.
LIPO
LISTED
NASDAQ
Lipella Pharmaceuticals to Present at Zacks SCR Life Sciences Virtual Investor Forum and Report Final Phase 2a Results in Oral Lichen Planus
News Preview
PITTSBURGH, Sept. 15, 2025 /PRNewswire/ -- Lipella Pharmaceuticals Inc. (OTC: LIPO) ("Lipella" or the "Company"), a clinical-stage biotechnology company transforming care with innovative mucosal delivery solutions, today announced that Jonathan Kaufman, Chief Executive Officer of Lipella, will present a corporate overview and final results from P...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson to showcase industry-leading neuropsychiatry innovations at the 2025 Psych Congress Annual Meeting
News Preview
21 abstracts from across the Company's portfolio highlight clinical and real-world data on major depressive disorder, treatment-resistant depression and schizophrenia
New Phase 3 data demonstrate the safety and efficacy of adjunctive seltorexant compared to quetiapine XR in major depressive disorder with insomnia symptoms
TITUSVILLE, N.J., Sept....
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf Expands Retail Footprint with Dispensary Openings in Florida and Ohio
News Preview
New locations in Apopka, Florida and Girard, Ohio bring Curaleaf's nationwide store count to 157
STAMFORD, Conn., Sept. 15, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of two new dispensaries; Cura...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf Expands Retail Footprint with Dispensary Openings in Florida and Ohio
News Preview
New locations in Apopka, Florida and Girard, Ohio bring Curaleaf's nationwide store count to 157
STAMFORD, Conn., Sept. 15, 2025 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of two new dispensaries; Curaleaf Ap...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US92790C1045
Viridian Therapeutics Inc
VRDN
LISTED
NASDAQ
Viridian Therapeutics Announces Completion of Enrollment in both REVEAL Clinical Trials and Positive Portfolio Updates
News Preview
Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced that enrollment is complete in REVEAL-1 and REVEAL-2, phase 3 clinical trials for VRDN-003 in patients with active and chronic TED, respectively....
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US50015M1099
Kodiak Sciences Inc
KOD
LISTED
NASDAQ
New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)
News Preview
Meaningful vision gains are rapidly achieved as early as week 4 and more than half of patients in the top two dose levels improved 3-lines or more on the eye chart (≥15 letter gain)A single dose of KSI-101 resulted in the majority of patients achieving resolution of intra-retinal and sub-retinal fluid and over 90% of patients achieved retinal dry...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US05350V1061
Avanos Medical Inc
AVNS
LISTED
NYSE
Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care
News Preview
ALPHARETTA, Ga., Sept. 15, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the acquisition of Nexus Medical, LLC, a privately held medical device company based in Lenexa, Kansas....
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: CA39986R1064
Grown Rogue International Inc.
GRIN
LISTED
CSE
Grown Rogue Expands Senior Credit Facility by US$5 Million
News Preview
Brings Total Facility to US$12 Million; Proceeds to Support Growth Initiatives
MEDFORD, Ore., Sept. 15, 2025 /CNW/ - Grown Rogue International Inc. ("Grown Rogue" or the "Company") (CSE: GRIN) (OTC: GRUSF), a flower-forward cannabis company combining craft values with disciplined execution, today announced it has secured an incremental US$5 milli...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: CA1380357048
Canopy Growth Corp
CGC
LISTED
NASDAQ
Canopy Growth Strengthens Balance Sheet with Early US$25 Million Term Loan Prepayment
News Preview
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that it completed an early prepayment of US$25 million (the “Prepayment”) against the Company’s senior secured term loan (the “Term Loan”).
The Co...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab
News Preview
Raludotatug deruxtecan (R-DXd) has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with platinum-resistant epithelial ovarian, primary peritoneal or fallopian tube cancers expressing CDH6 who have received prior treatment with bevacizumab.
Raludotatug deruxtec...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: JE00BYSS4X48
Novocure Ltd
NVCR
LISTED
NASDAQ
Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC)
News Preview
Novocure (NASDAQ: NVCR) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Optune Lua® for concurrent use with PD-1/PD-L1 inhibitors for the treatment of adult patients with unresectable advanced/recurrent non-small cell lung cancer (NSCLC) who have progressed on or after platinum-based chemotherapy.
“With the Mi...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US29089Q1058
Emergent BioSolutions Inc
EBS
LISTED
NYSE
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
News Preview
GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: CA82621K1021
Sienna Senior Living Inc
SIA
LISTED
TSX
Sienna Announces September Dividend
News Preview
MARKHAM, Ontario, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of September 2025, representing $0.936 per Common Share on an annualized basis....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: AU000000ACW3
Actinogen Medical Limited
ACW
LISTED
ASX
Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease
News Preview
Current XanaMIA pivotal phase 2/3 trial on track for interim analysis in January 2026 and final results late 2026 with trial enrolment expected to close in Q4 2025 Current XanaMIA pivotal phase 2/3 trial on track for interim analysis in January 2026 and final results late 2026 with trial enrolment expected to close in Q4 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US1276361086
Cadrenal Therapeutics, Inc.
CVKD
LISTED
NASDAQ
Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera’s Portfolio of Factor XIa Inhibitors
News Preview
PONTE VEDRA, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today announced the acquisition of the assets of eXIthera Pharmaceuticals (“eXIthera”), including its proprietary portfolio of investi...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: CA3018351047
Extendicare Inc
EXE
LISTED
TSX
Extendicare Announces September 2025 Dividend of C$0.042 per Share
News Preview
MARKHAM, Ontario, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of September 2025, which is payable on October 15, 2025 to shareholders of record at the close of business on September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US45782T1051
INmune Bio, Inc.
INMB
LISTED
NASDAQ
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult
News Preview
BOCA RATON, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (“INmune” or “the Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced the successful completion of its first full-scale pilot commercial...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
News Preview
$25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment options $25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potentia...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US5011471027
Krystal Biotech Inc
KRYS
LISTED
NASDAQ
Krystal Biotech Announces FDA Approval of Updated VYJUVEK® Label
News Preview
Revised label allows treatment of DEB patients from birth...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
News Preview
Bagsværd, Denmark, 15 September 2025 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved an update to the Rybelsus® (oral semaglutide) label to reflect the cardiovascular benefits seen in the SOUL trial. SOUL was a phase 3b trial carried out to evaluate the eff...
Themefolio
Profiler
Peergroup
© Newsfile
15.09.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Heal Wellness QSR Announces the Signing of a Franchise Agreement for Collingwood, Ontario
News Preview
Toronto, Ontario--(Newsfile Corp. - September 15, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce that Heal Wellness has signed a franchise agreement for the Collingwood area of Ontario. Heal Wellness ("Heal") is a quick-se...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.09.2025
ISIN: US6986681004
PAO Group, Inc.
PAOG
LISTED
OTC
PAO Group Inc Announces New CEO James Schramm
News Preview
OMAHA, NE / ACCESS Newswire / September 15, 2025 / PAO Group, Inc. (OTC:PAOG), today announced the appointment of James Schramm as Chief Executive Officer of PAO Group, Inc. In a meeting of the Board of Directors, Mr. Schramm was named CEO and James C DiPrima will step down as CEO and remain Chief Financial Officer. The action was taken in response...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US6979471090
Palvella Therapeutics Inc
PVLA
LISTED
NASDAQ
Palvella Therapeutics Completes Enrollment in Phase 2 TOIVA Trial of QTORIN™ Rapamycin for Cutaneous Venous Malformations
News Preview
Phase 2 TOIVA trial successfully met recruitment target, enrolling 16 subjects at leading vascular anomaly centers; top-line data expected in mid-December 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Altimmune Appoints Accomplished Commercial Executive Linda M. Richardson as Chief Commercial Officer
News Preview
GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced the appointment of Linda M. Richardson to the role of Chief Commercial Officer, effective September 16, 2025. Ms. R...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US02155X2053
Alterity Therapeutics Limited
ATHE
LISTED
NASDAQ
Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting
News Preview
ATH434 demonstrated clinically meaningful efficacy in modifying disease progression and was well tolerated at both 50 and 75 mg doses ATH434 demonstrated clinically meaningful efficacy in modifying disease progression and was well tolerated at both 50 and 75 mg doses...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US13471N3008
Can-Fite BioPharma Ltd.
CANF
LISTED
XASE
Can-Fite Reports Complete Resolution of Esophageal Varices in Decompensated Cirrhosis Patient Treated with Namodenoson
News Preview
Ramat Gan, Israel, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced a significant new clinical finding under its compassionate use program in decompensated...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US4158581094
Harrow Inc
HROW
LISTED
NASDAQ
Harrow Announces Agenda and Speakers for Investor & Analyst Day
News Preview
NASHVILLE, Tenn., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the agenda for its upcoming Investor & Analyst Day on Friday, September 26, from 11:30 a.m. ET to 3 p.m. ET in New York. The event will also be webcast live and instru...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US61225M1027
Monte Rosa Therapeutics Inc
GLUE
LISTED
NASDAQ
Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases
News Preview
Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.09.2025
ISIN: US74366E1029
Protagonist Therapeutics Inc
PTGX
LISTED
NASDAQ
Protagonist Announces Icotrokinra Phase 2b ANTHEM-UC Trial Data to be Presented at the United European Gastroenterology Week Berlin 2025
News Preview
NEWARK, CALIFORNIA / ACCESS Newswire / September 15, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that data from the Phase 2b ANTHEM-UC study with icotrokinra in ulcerative colitis will be the focus of a brief oral presentation at the United European Gastroenterology Week 2025 being held in Be...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.09.2025
ISIN: US67577C1053
Ocugen Inc
OCGN
LISTED
NASDAQ
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
News Preview
MALVERN, Pa., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today executed a licensing agreement with Kwangdong Pharmaceutical, Co., Ltd., (“Kwangdong”) one of the leading pharmaceutical companies in Korea, for the exclusive K...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ANRO
News Preview
LOS ANGELES, Sept. 15, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Alto Neuroscience, Inc. ("Alto " or "the Company") (NYSE: ANRO ) for violations of the federal securities laws.
Shareholders who purchased shares of Alto during the class period listed are encouraged to contact the firm regarding po...
Themefolio
Profiler
Peergroup
© PR Newswire
15.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Sept. 15, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against Alto Neuroscience, Inc. ("Alto Neuroscience" or "the Company") (NYSE: ANRO) for violations of the federal securities laws....
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025
News Preview
DexCom, Inc. (Nasdaq: DXCM), a global leader in glucose biosensing, will present new product features and a compilation of new evidence that shows the benefits of its glucose biosensing technology for people with all types of diabetes at the upcoming 61st annual European Association for the Study of Diabetes (EASD) Conference.
This press release...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.09.2025
ISIN: US29415J1060
enVVeno Medical Corporation
NVNO
LISTED
NASDAQ
enVVeno Medical Updates Regulatory Status of VenoValve(R)
News Preview
IRVINE, CA / ACCESS Newswire / September 15, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that it will file a request for supervisory appeal of the not-approvable letter from the Center for Devices...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
